Results 141 to 150 of about 16,668 (262)
Anti-TNF-Related Medium-Vessel Vasculitis: A Report of a Rare Adverse Drug Reaction. [PDF]
Hassas Yeganeh M +5 more
europepmc +1 more source
Perspectives on managing skin manifestations in cancer patients: a multidisciplinary mixed-method survey of oncologists and dermatologists. [PDF]
Fattore D +5 more
europepmc +1 more source
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea +5 more
wiley +1 more source
Cutaneous Laser Therapy for Residual Limb Skin Pathology: A Narrative Review Bridging Dermatologic Laser Research With Clinical Perspectives and Considerations for Multidisciplinary Care Teams. [PDF]
Lannan FM +6 more
europepmc +1 more source
What's new? Mitogen‐activated protein kinase (MAPK) inhibitors are promising treatments for pediatric Langerhans cell histiocytosis (LCH), a rare heterogeneous neoplasm that often affects multiple organ systems. Which MAPK inhibitors are most effective against LCH remains uncertain.
Xue Tang +5 more
wiley +1 more source
Tocilizumab-induced psoriatic dermatitis in polyarticular juvenile idiopathic arthritis: A rare case report. [PDF]
Rajesh RY +7 more
europepmc +1 more source
Abstract Background Episiotomy is a common obstetric procedure often associated with significant postpartum pain and delayed wound healing. Conventional treatments provide limited relief and might not be suitable for all women. Energy‐based therapies, including infrared irradiation and low‐level laser therapy (LLLT), a non‐thermal photo biomodulation ...
Shira Regev‐Sadeh +4 more
wiley +1 more source
Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review. [PDF]
El-Amawy HS.
europepmc +1 more source

